Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Addition to the Russell 2000 Index

GlobeNewswireMay 25, 2023 08:01 ET

Ocean Biomedical, Inc. Enters Into a $25 Million Convertible Note Facility

GlobeNewswireMay 16, 2023 08:01 ET

Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias.

GlobeNewswireApr 20, 2023 08:06 ET

Ocean Biomedical (NASDAQ: OCEA) Will Target Pulmonary Fibrosis Discoveries as Novel Treatments of Hermansky-Pudlak Syndrome

GlobeNewswireApr 6, 2023 08:05 ET

Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. With a "Buy" Recommendation

GlobeNewswireMar 16, 2023 08:07 ET

Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton With a "Buy" Recommendation

GlobeNewswireMar 14, 2023 08:02 ET